Cytokinetics grants 52,834 inducement stock options at USD 69.31 strike price

• Cytokinetics granted inducement equity awards on Sept. 15, 2026 to 23 new employees hired in August-September 2026.
• Stock options cover 52,834 shares with an exercise price of $69.31, matching the Sept. 15 closing price; options run 10 years.
• Options vest over four years: 25% after one year, then monthly over the next 36 months, subject to continued service.
• RSUs total 35,025 shares, vesting over three years: 40% year one, 40% year two, 20% year three.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609171600PRIMZONEFULLFEED9829207) on September 17, 2026, and is solely responsible for the information contained therein.